|
HY-106961-10mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-100mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-25mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-5mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-50mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961A-1mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
|
HY-106961A-5mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
|
HY-111925-1mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111925-10mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111925-100mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111925-5mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111925-50mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-122331-100mg
|
MedChemexpress LLC
|
Norbormide [CAS 991-42-4]
|
|
|
|
|
HY-13213-10mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13213-100mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13213-5mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13213-50mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13438-10mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-25mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-5mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-50mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-P1256C-5mg
|
MedChemexpress LLC
|
JMV 449 (acetate) [CAS 141863-45-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111925-1mL
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13213-1mL
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13438-1mL
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
